Stockreport

IN8bio cuts staff and pipeline to focus on AML cell therapy [Yahoo! Finance]

IN8bio, Inc.  (INAB) 
PDF As part of the strategic restructuring, the US-based company will reduce its headcount by about 49% and suspend enrolment in the glioblastoma development programme. I [Read more]